First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.

J. J. Ko; T. K. Choueiri; B. I. Rini; J. L. Lee; N. Kroeger; S. Srinivas; L. C. Harshman; J. J. Knox; G. A. Bjarnason; M. J. MacKenzie; L. Wood; U. N. Vaishampayan; N. Agarwal; S. K. Pal; M. H. Tan; S. Y. Rha; T. Yuasa; F. Donskov; A. Bamias; D. Y. Heng

doi:10.1038/bjc.2014.25

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.

J. J. Ko, T. K. Choueiri, B. I. Rini, J. L. Lee, N. Kroeger, S. Srinivas, L. C. Harshman, J. J. Knox, G. A. Bjarnason, M. J. MacKenzie, L. Wood, U. N. Vaishampayan, N. Agarwal, S. K. Pal, M. H. Tan, S. Y. Rha, T. Yuasa, F. Donskov, A. Bamias, D. Y. Heng

科研成果: 期刊稿件 › 文章 › 同行评审

65 引用（Scopus）

源语言	英语
页（从-至）	1917-1922
页数	6
期刊	British Journal of Cancer
卷	110
期	8
DOI	https://doi.org/10.1038/bjc.2014.25
出版状态	已出版 - 4月 15 2014
已对外发布	是

!!!ASJC Scopus Subject Areas

肿瘤学
癌症研究

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1038/bjc.2014.25

其它文件与链接

引用此

Ko, J. J., Choueiri, T. K., Rini, B. I., Lee, J. L., Kroeger, N., Srinivas, S., Harshman, L. C., Knox, J. J., Bjarnason, G. A., MacKenzie, M. J., Wood, L., Vaishampayan, U. N., Agarwal, N., Pal, S. K., Tan, M. H., Rha, S. Y., Yuasa, T., Donskov, F., Bamias, A., & Heng, D. Y. (2014). First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC. British Journal of Cancer, 110(8), 1917-1922. https://doi.org/10.1038/bjc.2014.25

Ko, JJ, Choueiri, TK, Rini, BI, Lee, JL, Kroeger, N, Srinivas, S, Harshman, LC, Knox, JJ, Bjarnason, GA, MacKenzie, MJ, Wood, L, Vaishampayan, UN, Agarwal, N, Pal, SK, Tan, MH, Rha, SY, Yuasa, T, Donskov, F, Bamias, A & Heng, DY 2014, 'First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.', British Journal of Cancer, 卷 110, 号码 8, 页码 1917-1922. https://doi.org/10.1038/bjc.2014.25

@article{5b10527397114de8aba22bd8a6700c2f,

title = "First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.",

author = "Ko, {J. J.} and Choueiri, {T. K.} and Rini, {B. I.} and Lee, {J. L.} and N. Kroeger and S. Srinivas and Harshman, {L. C.} and Knox, {J. J.} and Bjarnason, {G. A.} and MacKenzie, {M. J.} and L. Wood and Vaishampayan, {U. N.} and N. Agarwal and Pal, {S. K.} and Tan, {M. H.} and Rha, {S. Y.} and T. Yuasa and F. Donskov and A. Bamias and Heng, {D. Y.}",

year = "2014",

month = apr,

day = "15",

doi = "10.1038/bjc.2014.25",

language = "English",

volume = "110",

pages = "1917--1922",

journal = "British Journal of Cancer",

issn = "0007-0920",

publisher = "Nature Publishing Group",

number = "8",

}

TY - JOUR

T1 - First-, second-, third-line therapy for mRCC

T2 - benchmarks for trial design from the IMDC.

AU - Ko, J. J.

AU - Choueiri, T. K.

AU - Rini, B. I.

AU - Lee, J. L.

AU - Kroeger, N.

AU - Srinivas, S.

AU - Harshman, L. C.

AU - Knox, J. J.

AU - Bjarnason, G. A.

AU - MacKenzie, M. J.

AU - Wood, L.

AU - Vaishampayan, U. N.

AU - Agarwal, N.

AU - Pal, S. K.

AU - Tan, M. H.

AU - Rha, S. Y.

AU - Yuasa, T.

AU - Donskov, F.

AU - Bamias, A.

AU - Heng, D. Y.

PY - 2014/4/15

Y1 - 2014/4/15

UR - http://www.scopus.com/inward/record.url?scp=84901844215&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84901844215&partnerID=8YFLogxK

U2 - 10.1038/bjc.2014.25

DO - 10.1038/bjc.2014.25

M3 - Article

C2 - 24691425

AN - SCOPUS:84901844215

SN - 0007-0920

VL - 110

SP - 1917

EP - 1922

JO - British Journal of Cancer

JF - British Journal of Cancer

IS - 8

ER -

First-, second-, third-line therapy for mRCC: benchmarks for trial design from the IMDC.

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此